Replies to post #130728 on NanoViricides Inc. (NNVC)

[arvitar]

Has the Moffat lab developed their shingles model to the point of being acceptable for testing NNVC's candidate?

At the recent Shareholder meeting, Seymour and Diwan said that Moffat's shingles model was then currently inadequate, and required further development.

[Its_lose_not_loose]

Heard this someplace before. Positive conclusions based on iffy hypotheses.

Moffat seems to be competent; nanoviricides seem to work.
Conclusion: We will hear positive things from Moffat.
We should have a final candidate that can go to tox.